Literature DB >> 23320050

The intestinal microbiota dysbiosis and Clostridium difficile infection: is there a relationship with inflammatory bowel disease?

Justyna Bien1, Vindhya Palagani, Przemyslaw Bozko.   

Abstract

Gut microbiota is a compilation of microorganisms dwelling in the entire mammalian gastrointestinal tract. They display a symbiotic relationship with the host contributing to its intestinal health and disease. Even a slight fluctuation in this equipoise may be deleterious to the host, leading to many pathological conditions like Clostridium difficile infection or inflammatory bowel disease (IBD). In this review, we focus on the role of microbial dysbiosis in initiation of C. difficile infection and IBD, and we also touch upon the role of specific pathogens, particularly C. difficile, as causative agents of IBD. We also discuss the molecular mechanisms activated by C. difficile that contribute to the development and exacerbation of gastrointestinal disorders.

Entities:  

Keywords:  Clostridium difficile; inflammatory bowel disease; microbial dysbiosis

Year:  2013        PMID: 23320050      PMCID: PMC3539291          DOI: 10.1177/1756283X12454590

Source DB:  PubMed          Journal:  Therap Adv Gastroenterol        ISSN: 1756-283X            Impact factor:   4.409


  131 in total

Review 1.  Microbial factors in inflammatory bowel disease.

Authors:  Richard J Farrell; J Thomas LaMont
Journal:  Gastroenterol Clin North Am       Date:  2002-03       Impact factor: 3.806

2.  "Diversion" colitis caused by Clostridium difficile infection: report of a case.

Authors:  Effie Tsironi; Peter M Irving; Roger M Feakins; David S Rampton
Journal:  Dis Colon Rectum       Date:  2006-07       Impact factor: 4.585

3.  C. difficile toxin A increases intestinal permeability and induces Cl- secretion.

Authors:  R Moore; C Pothoulakis; J T LaMont; S Carlson; J L Madara
Journal:  Am J Physiol       Date:  1990-08

4.  Cross-feeding between Bifidobacterium longum BB536 and acetate-converting, butyrate-producing colon bacteria during growth on oligofructose.

Authors:  Gwen Falony; Angeliki Vlachou; Kristof Verbrugghe; Luc De Vuyst
Journal:  Appl Environ Microbiol       Date:  2006-10-20       Impact factor: 4.792

5.  Mucosal flora in inflammatory bowel disease.

Authors:  Alexander Swidsinski; Axel Ladhoff; Annelie Pernthaler; Sonja Swidsinski; Vera Loening-Baucke; Marianne Ortner; Jutta Weber; Uwe Hoffmann; Stefan Schreiber; Manfred Dietel; Herbert Lochs
Journal:  Gastroenterology       Date:  2002-01       Impact factor: 22.682

6.  Clostridium difficile toxin B activates the EGF receptor and the ERK/MAP kinase pathway in human colonocytes.

Authors:  Xi Na; Dezheng Zhao; Hon Wai Koon; Ho Kim; Johanna Husmark; Mary P Moyer; Charalabos Pothoulakis; J Thomas LaMont
Journal:  Gastroenterology       Date:  2005-04       Impact factor: 22.682

7.  IL-8 release and neutrophil activation by Clostridium difficile toxin-exposed human monocytes.

Authors:  J K Linevsky; C Pothoulakis; S Keates; M Warny; A C Keates; J T Lamont; C P Kelly
Journal:  Am J Physiol       Date:  1997-12

Review 8.  The causes of intestinal dysbiosis: a review.

Authors:  Jason A Hawrelak; Stephen P Myers
Journal:  Altern Med Rev       Date:  2004-06

9.  Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors.

Authors:  H Daub; F U Weiss; C Wallasch; A Ullrich
Journal:  Nature       Date:  1996-02-08       Impact factor: 49.962

10.  Development of the human infant intestinal microbiota.

Authors:  Chana Palmer; Elisabeth M Bik; Daniel B DiGiulio; David A Relman; Patrick O Brown
Journal:  PLoS Biol       Date:  2007-06-26       Impact factor: 8.029

View more
  67 in total

Review 1.  Pathogenesis of Crohn's disease: Bug or no bug.

Authors:  Marta Maia Bosca-Watts; Joan Tosca; Rosario Anton; Maria Mora; Miguel Minguez; Francisco Mora
Journal:  World J Gastrointest Pathophysiol       Date:  2015-02-15

2.  The impact of Lactococcus lactis (probiotic nasal rinse) co-culture on growth of patient-derived strains of Pseudomonas aeruginosa.

Authors:  Do-Yeon Cho; Daniel Skinner; Dong Jin Lim; John G Mclemore; Connor G Koch; Shaoyan Zhang; William E Swords; Ryan Hunter; David K Crossman; Michael R Crowley; Jessica W Grayson; Steven M Rowe; Bradford A Woodworth
Journal:  Int Forum Allergy Rhinol       Date:  2020-01-10       Impact factor: 3.858

Review 3.  The intestinal microbiome and surgical disease.

Authors:  Monika A Krezalek; Kinga B Skowron; Kristina L Guyton; Baddr Shakhsheer; Sanjiv Hyoju; John C Alverdy
Journal:  Curr Probl Surg       Date:  2016-06-14       Impact factor: 1.909

Review 4.  Natural products as mediators of disease.

Authors:  Neha Garg; Tal Luzzatto-Knaan; Alexey V Melnik; Andrés Mauricio Caraballo-Rodríguez; Dimitrios J Floros; Daniel Petras; Rachel Gregor; Pieter C Dorrestein; Vanessa V Phelan
Journal:  Nat Prod Rep       Date:  2016-11-22       Impact factor: 13.423

5.  Fecal Microbiota Transplant Restores Mucosal Integrity in a Murine Model of Burn Injury.

Authors:  Joshua W Kuethe; Stephanie M Armocida; Emily F Midura; Teresa C Rice; David A Hildeman; Daniel P Healy; Charles C Caldwell
Journal:  Shock       Date:  2016-06       Impact factor: 3.454

Review 6.  Intestinal microbiota pathogenesis and fecal microbiota transplantation for inflammatory bowel disease.

Authors:  Zi-Kai Wang; Yun-Sheng Yang; Ye Chen; Jing Yuan; Gang Sun; Li-Hua Peng
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

Review 7.  Clostridium difficile and inflammatory bowel disease: role in pathogenesis and implications in treatment.

Authors:  Orna Nitzan; Mazen Elias; Bibiana Chazan; Raul Raz; Walid Saliba
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

8.  Escherichia coli Nissle 1917 protects gnotobiotic pigs against human rotavirus by modulating pDC and NK-cell responses.

Authors:  Anastasia N Vlasova; Lulu Shao; Sukumar Kandasamy; David D Fischer; Abdul Rauf; Stephanie N Langel; Kuldeep S Chattha; Anand Kumar; Huang-Chi Huang; Gireesh Rajashekara; Linda J Saif
Journal:  Eur J Immunol       Date:  2016-08-11       Impact factor: 5.532

Review 9.  Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.

Authors:  Nancy Fu; Titus Wong
Journal:  Curr Infect Dis Rep       Date:  2016-06       Impact factor: 3.725

10.  Alcohol enhances symptoms and propensity for infection in inflammatory bowel disease patients and a murine model of DSS-induced colitis.

Authors:  Abigail R Cannon; Paulius V Kuprys; Adrienne N Cobb; Xianzhong Ding; Anai N Kothari; Paul C Kuo; Joshua M Eberhardt; Adam M Hammer; Niya L Morris; Xiaoling Li; Mashkoor A Choudhry
Journal:  J Leukoc Biol       Date:  2018-05-18       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.